Nanosep centrifugal filtration device for ultrafiltration.
Nanosep centrifugal filtration device
Not only proteins and nucleic acids, but also has a proven track record in the purification of viruses and extracellular vesicles!
NanoSep is a centrifugal device for ultrafiltration that incorporates a membrane (Omega membrane) in a 1.5 mL tube size. It is suitable for sample volumes of 50 - 500 µL and is effective for the purification and desalting of small-scale proteins and nucleic acids. For example, it can be used for sample preparation and SDS removal in protein or peptide analysis using LC/MS. Additionally, recent studies have utilized NanoSep with a 300K MWCO (molecular weight cut-off) for the purification of SARS-CoV-2 virus present in human nasopharyngeal swabs. - Rapid sample processing time - Low protein adsorption Omega (modified PES) membrane - Wide range of molecular weight cut-offs - Leak prevention of concentrated solutions into the receiver using ultrasonic sealing technology
Inquire About This Product
basic information
The NanoSep centrifugal filtration device is an ultrafiltration filter based on a 1.5 mL tube. It features a color-coded design for each MWCO. Selectable fraction molecular weights (MWCO): - 3K, Gray - 10K, Blue - 30K, Red - 100K, Clear - 300K, Orange
Price range
Delivery Time
Applications/Examples of results
- Concentration, purification, and desalting of peptides, proteins, oligonucleotides, and DNA/RNA - Recovery of DNA from agarose gel slices - Recovery of proteins from polyacrylamide gel - Purification and separation of viruses and extracellular vesicles
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
